Breaking News Instant updates and real-time market news.

DKNG

DraftKings

$14.90 /

+0.035 (+0.24%)

04:40
11/18/22
11/18
04:40
11/18/22
04:40

DraftKings initiated with an Overweight at Piper Sandler

Piper Sandler analyst Matt Farrell initiated coverage of DraftKings with an Overweight rating and $21 price target. DraftKings is a leader in the online sports betting market with a growing presence in internet gaming, which combined represent an $80B total addressable market between the United States and Canada, Farrell tells investors in a research note. With profitability expectations reset after the initial 2023 guide, current share levels represent an attractive long-term entry point, particularly with the risk of a future capital raise "largely diminished," says the analyst.

  • 18

    Nov

  • 30

    Nov

OTHER BREAKING NEWS FROM THE FLY

Earnings
Notable companies reporting before tomorrow's open » 13:13
03/27/23
03/27
13:13
03/27/23
13:13
WBA

Walgreens Boots Alliance

$33.10 /

+0.4 (+1.22%)

Notable companies…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WBA Walgreens Boots Alliance
$33.10 /

+0.4 (+1.22%)

WBA Walgreens Boots Alliance
$33.10 /

+0.4 (+1.22%)

03/26/23 Barclays
Walgreens Boots Alliance price target lowered to $43 from $45 at Barclays
03/22/23 Evercore ISI
Walgreens Boots Alliance price target lowered to $35 from $36 at Evercore ISI
02/23/23 Loop Capital
Loop Capital starts Walgreens Boots at Buy, sees higher growth from healthcare
02/22/23 Loop Capital
Walgreens Boots Alliance initiated with a Buy at Loop Capital
WBA Walgreens Boots Alliance
$33.10 /

+0.4 (+1.22%)

WBA Walgreens Boots Alliance
$33.10 /

+0.4 (+1.22%)

WBA Walgreens Boots Alliance
$33.10 /

+0.4 (+1.22%)

WBA Walgreens Boots Alliance
$33.10 /

+0.4 (+1.22%)

General news
2-year note auction » 13:09
03/27/23
03/27
13:09
03/27/23
13:09
$ECON

Economic Data

/

+

Total Amount: $42B, Rate:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Nano Dimension files lawsuit against Murchinson, Anson and Boothbay » 13:08
03/27/23
03/27
13:08
03/27/23
13:08
NNDM

Nano Dimension

$2.60 /

+0.01 (+0.39%)

Nano Dimension has filed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NNDM Nano Dimension
$2.60 /

+0.01 (+0.39%)

NNDM Nano Dimension
$2.60 /

+0.01 (+0.39%)

03/10/23 Lake Street
Nano Dimension made 'lowball offer' Stratasys won't accept, says Lake Street
NNDM Nano Dimension
$2.60 /

+0.01 (+0.39%)

NNDM Nano Dimension
$2.60 /

+0.01 (+0.39%)

NNDM Nano Dimension
$2.60 /

+0.01 (+0.39%)

NNDM Nano Dimension
$2.60 /

+0.01 (+0.39%)

Upgrade
Novartis upgraded to Hold at Deutsche Bank after Kisqali's 'positive surprise' » 13:07
03/27/23
03/27
13:07
03/27/23
13:07
NVS

Novartis

$90.14 /

+6.555 (+7.84%)

Deutsche Bank upgraded…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$90.14 /

+6.555 (+7.84%)

NVS Novartis
$90.14 /

+6.555 (+7.84%)

12:59 Today Deutsche Bank
Novartis upgraded to Hold from Sell at Deutsche Bank
07:24 Today BofA
Novartis' NATALEE readout a 'best case scenario,' says BofA
07:18 Today Morgan Stanley
Morgan Stanley expects Novartis to outperform after Kisqali 'positive surprise'
01/26/23 Citi
Novartis downgraded to Neutral from Buy at Citi
NVS Novartis
$90.14 /

+6.555 (+7.84%)

NVS Novartis
$90.14 /

+6.555 (+7.84%)

NVS Novartis
$90.14 /

+6.555 (+7.84%)

NVS Novartis
$90.14 /

+6.555 (+7.84%)

Conference/Events
Compass Pathways management to meet virtually with Cantor Fitzgerald » 13:06
03/27/23
03/27
13:06
03/27/23
13:06
CMPS

Compass Pathways

$10.28 /

+0.26 (+2.59%)

Virtual Meetings to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMPS Compass Pathways
$10.28 /

+0.26 (+2.59%)

CMPS Compass Pathways
$10.28 /

+0.26 (+2.59%)

01/09/23 Loop Capital
Atai Life Sciences price target lowered to $10 from $18 at Loop Capital
12/15/22 EF Hutton
Compass Pathways initiated with a Buy at EF Hutton
12/09/22 Oppenheimer
Compass Pathways price target lowered to $33 from $55 at Oppenheimer
11/01/22 Loop Capital
Compass Pathways initiated with a Buy at Loop Capital
CMPS Compass Pathways
$10.28 /

+0.26 (+2.59%)

CMPS Compass Pathways
$10.28 /

+0.26 (+2.59%)

CMPS Compass Pathways
$10.28 /

+0.26 (+2.59%)

Options
PVH Corp. options imply 5.1% move in share price post-earnings » 13:04
03/27/23
03/27
13:04
03/27/23
13:04
PVH

PVH Corp.

$73.70 /

+0.795 (+1.09%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PVH PVH Corp.
$73.70 /

+0.795 (+1.09%)

PVH PVH Corp.
$73.70 /

+0.795 (+1.09%)

03/21/23 UBS
PVH Corp. price target lowered to $92 from $100 at UBS
03/20/23 Goldman Sachs
PVH Corp. price target raised to $74 from $67 at Goldman Sachs
02/15/23 Wells Fargo
PVH Corp. price target raised to $110 from $85 at Wells Fargo
01/23/23 JPMorgan
PVH Corp. price target raised to $95 from $77 at JPMorgan
PVH PVH Corp.
$73.70 /

+0.795 (+1.09%)

PVH PVH Corp.
$73.70 /

+0.795 (+1.09%)

Hot Stocks
CN, Trealmont, Kaptan plan for new Calgary intermodal transload facility » 13:02
03/27/23
03/27
13:02
03/27/23
13:02
CNI

Canadian National

$114.65 /

+0.95 (+0.84%)

CN, Trealmont Transport…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNI Canadian National
$114.65 /

+0.95 (+0.84%)

CNI Canadian National
$114.65 /

+0.95 (+0.84%)

07:12 Today BofA
Canadian National price target lowered to $134 from $137 at BofA
01/25/23 Desjardins
Canadian National price target lowered to C$179 from C$180 at Desjardins
01/25/23 CIBC
Canadian National price target lowered to C$175 from C$181 at CIBC
01/25/23 BMO Capital
Canadian National price target lowered to C$180 from C$185 at BMO Capital
CNI Canadian National
$114.65 /

+0.95 (+0.84%)

CNI Canadian National
$114.65 /

+0.95 (+0.84%)

CNI Canadian National
$114.65 /

+0.95 (+0.84%)

Upgrade
Novartis upgraded to Hold from Sell at Deutsche Bank » 12:59
03/27/23
03/27
12:59
03/27/23
12:59
NVS

Novartis

$90.21 /

+6.625 (+7.93%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$90.21 /

+6.625 (+7.93%)

NVS Novartis
$90.21 /

+6.625 (+7.93%)

07:24 Today BofA
Novartis' NATALEE readout a 'best case scenario,' says BofA
07:18 Today Morgan Stanley
Morgan Stanley expects Novartis to outperform after Kisqali 'positive surprise'
01/26/23 Citi
Novartis downgraded to Neutral from Buy at Citi
01/24/23 Lake Street
Harrow Health price target raised to $24 from $17 at Lake Street
NVS Novartis
$90.21 /

+6.625 (+7.93%)

NVS Novartis
$90.21 /

+6.625 (+7.93%)

NVS Novartis
$90.21 /

+6.625 (+7.93%)

NVS Novartis
$90.21 /

+6.625 (+7.93%)

Hot Stocks
BioMarin granted orphan status for DMD treatment » 12:58
03/27/23
03/27
12:58
03/27/23
12:58
BMRN

BioMarin

$91.67 /

+0.985 (+1.09%)

The FDA granted BioMarin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMRN BioMarin
$91.67 /

+0.985 (+1.09%)

BMRN BioMarin
$91.67 /

+0.985 (+1.09%)

03/21/23 Bernstein
BioMarin initiated with an Underperform at Bernstein
03/09/23 Chardan
Tenaya Therapeutics price target lowered to $24 from $28 at Chardan
02/28/23 Stifel
BioMarin price target raised to $118 from $114 at Stifel
02/28/23 Wedbush
BioMarin price target lowered to $74 from $83 at Wedbush
BMRN BioMarin
$91.67 /

+0.985 (+1.09%)

BMRN BioMarin
$91.67 /

+0.985 (+1.09%)

Hot Stocks
Incyte granted orphan status for myelofibrosis treatment » 12:57
03/27/23
03/27
12:57
03/27/23
12:57
INCY

Incyte

$70.82 /

+0.59 (+0.84%)

The FDA granted Incyte…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$70.82 /

+0.59 (+0.84%)

INCY Incyte
$70.82 /

+0.59 (+0.84%)

03/24/23 SVB Securities
Incyte upgraded to Market Perform at SVB after ruxolitinib XR CRL, Zynz approval
03/24/23 SVB Securities
Incyte upgraded to Market Perform from Underperform at SVB Securities
03/24/23 BofA
BofA sees minimal near-term impact on Incyte from ruxolitinib ER CRL
02/08/23 Cowen
Incyte price target raised to $100 from $95 at Cowen
INCY Incyte
$70.82 /

+0.59 (+0.84%)

INCY Incyte
$70.82 /

+0.59 (+0.84%)

INCY Incyte
$70.82 /

+0.59 (+0.84%)

Hot Stocks
Centene appoints Tanya McNally as Chief People Officer » 12:49
03/27/23
03/27
12:49
03/27/23
12:49
CNC

Centene

$64.58 /

+0.545 (+0.85%)

Centene announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNC Centene
$64.58 /

+0.545 (+0.85%)

CNC Centene
$64.58 /

+0.545 (+0.85%)

03/21/23 Wells Fargo
Molina Healthcare price target lowered to $282 from $307 at Wells Fargo
03/21/23 Wells Fargo
Centene price target lowered to $71 from $79 at Wells Fargo
03/08/23 Deutsche Bank
Centene downgraded to Hold on estimate risk at Deutsche Bank
03/08/23 Deutsche Bank
Centene downgraded to Hold from Buy at Deutsche Bank
CNC Centene
$64.58 /

+0.545 (+0.85%)

CNC Centene
$64.58 /

+0.545 (+0.85%)

CNC Centene
$64.58 /

+0.545 (+0.85%)

CNC Centene
$64.58 /

+0.545 (+0.85%)

Hot Stocks
Kludein I Acquisition Corp trading resumes  12:43
03/27/23
03/27
12:43
03/27/23
12:43
NIR

Near Intelligence

$6.20 /

-6.15 (-49.80%)

 
ShowHide Related Items >><<
NIR Near Intelligence
$6.20 /

-6.15 (-49.80%)

Conference/Events
Payoneer Global management to meet with Cantor Fitzgerald » 12:40
03/27/23
03/27
12:40
03/27/23
12:40
PAYO

Payoneer Global

$6.06 /

+0.015 (+0.25%)

Group luncheon meeting…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PAYO Payoneer Global
$6.06 /

+0.015 (+0.25%)

PAYO Payoneer Global
$6.06 /

+0.015 (+0.25%)

02/27/23 Jefferies
Payoneer Global initiated with a Buy at Jefferies
01/11/23 Wolfe Research
Payoneer Global initiated with an Outperform at Wolfe Research
12/30/22 Northland
Payoneer Global named a top pick for 2023 at Northland
11/10/22 Citi
Payoneer Global price target raised to $10 from $9 at Citi
PAYO Payoneer Global
$6.06 /

+0.015 (+0.25%)

PAYO Payoneer Global
$6.06 /

+0.015 (+0.25%)

PAYO Payoneer Global
$6.06 /

+0.015 (+0.25%)

Hot Stocks
Kludein I Acquisition Corp trading halted, volatility trading pause  12:38
03/27/23
03/27
12:38
03/27/23
12:38
NIR

Near Intelligence

$6.20 /

-6.15 (-49.80%)

 
ShowHide Related Items >><<
NIR Near Intelligence
$6.20 /

-6.15 (-49.80%)

Downgrade
Jounce Therapeutics downgraded to Neutral from Overweight at Piper Sandler » 12:37
03/27/23
03/27
12:37
03/27/23
12:37
JNCE

Jounce Therapeutics

$1.86 /

+0.35 (+23.26%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNCE Jounce Therapeutics
$1.86 /

+0.35 (+23.26%)

JNCE Jounce Therapeutics
$1.86 /

+0.35 (+23.26%)

02/24/23 SMBC Nikko
Jounce Therapeutics downgraded to Neutral from Outperform at SMBC Nikko
02/23/23 Raymond James
Jounce downgraded to Market Perform from Outperform at Raymond James
01/02/23 Piper Sandler
Piper Sandler keeps Overweight on Jounce Therapeutics, lowers price target to $5
11/11/22 Raymond James
Raymond James downgrades Jounce to Outperform on ILT inhibitor data
JNCE Jounce Therapeutics
$1.86 /

+0.35 (+23.26%)

JNCE Jounce Therapeutics
$1.86 /

+0.35 (+23.26%)

Conference/Events
Haynes management to meet virtually with Benchmark » 12:25
03/27/23
03/27
12:25
03/27/23
12:25
HAYN

Haynes

$48.55 /

+1.05 (+2.21%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAYN Haynes
$48.55 /

+1.05 (+2.21%)

02/16/23 Noble Capital
Haynes initiated with an Outperform at Noble Capital
11/15/22 KeyBanc
Haynes downgraded to Sector Weight from Overweight at KeyBanc
07/08/22 KeyBanc
KeyBanc cuts price targets on aerospace materials sub-sector
04/01/22 KeyBanc
Haynes price target raised to $55 from $41 at KeyBanc
HAYN Haynes
$48.55 /

+1.05 (+2.21%)

HAYN Haynes
$48.55 /

+1.05 (+2.21%)

Recommendations
JPMorgan strategist says Q1 likely high point for equities this year » 12:24
03/27/23
03/27
12:24
03/27/23
12:24
$ECON

Economic Data

/

+

, SPX

S&P 500

/

+

, SPY

SPDR S&P 500 ETF Trust

$395.73 /

+0.005 (+0.00%)

JPMorgan's Global…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$395.73 /

+0.005 (+0.00%)

$ECON Economic Data
/

+

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$395.73 /

+0.005 (+0.00%)

$ECON Economic Data
/

+

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$395.73 /

+0.005 (+0.00%)

$ECON Economic Data
/

+

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$395.73 /

+0.005 (+0.00%)

SPX S&P 500
/

+

$ECON Economic Data
/

+

SPX S&P 500
/

+

SPY SPDR S&P 500 ETF Trust
$395.73 /

+0.005 (+0.00%)

Recommendations
Vislink price target lowered to $1 from $1.25 at Alliance Global Partners » 12:19
03/27/23
03/27
12:19
03/27/23
12:19
VISL

Vislink

/

+

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VISL Vislink
/

+

VISL Vislink
/

+

11/15/22 Alliance Global Partners
Vislink price target lowered to $1.25 from $1.75 at Alliance Global Partners
VISL Vislink
/

+

Technical Analysis
NASDAQ market internals summary » 12:17
03/27/23
03/27
12:17
03/27/23
12:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

General news
Fed's Barr repeated the line that the banking system is "sound and resilient," » 12:15
03/27/23
03/27
12:15
03/27/23
12:15
$ECON

Economic Data

/

+

Fed's Barr repeated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Recommendations
Farmers Edge price target lowered to C$0.30 from C$0.45 at Raymond James » 12:14
03/27/23
03/27
12:14
03/27/23
12:14
FMEGF

Farmers Edge

/

+

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FMEGF Farmers Edge
/

+

03/17/23 Canaccord
Farmers Edge price target lowered to C$0.25 from C$0.40 at Canaccord
01/26/23 National Bank
Farmers Edge price target lowered to C$0.25 from C$0.30 at National Bank
11/16/22 Canaccord
Farmers Edge price target lowered to C$0.40 from C$1 at Canaccord
10/20/22 National Bank
Farmers Edge price target lowered to C$0.50 from C$1 at National Bank
Recommendations
Knight Therapeutics price target lowered to C$6.50 from C$7.50 at RBC Capital » 12:13
03/27/23
03/27
12:13
03/27/23
12:13
KHTRF

Knight Therapeutics

$3.47 /

-0.1065 (-2.98%)

RBC Capital lowered the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KHTRF Knight Therapeutics
$3.47 /

-0.1065 (-2.98%)

KHTRF Knight Therapeutics
$3.47 /

-0.1065 (-2.98%)

04:24 Today National Bank
Knight Therapeutics downgraded to Sector Perform at National Bank
08/12/22 Stifel
Knight Therapeutics price target raised to C$5.40 from C$5.30 at Stifel
05/13/22 Canaccord
Knight Therapeutics price target lowered to C$6.75 from C$7 at Canaccord
KHTRF Knight Therapeutics
$3.47 /

-0.1065 (-2.98%)

Recommendations
Patriot Battery Metals price target raised to C$16.75 from C$16.50 at Canaccord » 12:12
03/27/23
03/27
12:12
03/27/23
12:12
PMETF

Patriot Battery Metals

$8.35 /

+0.126 (+1.53%)

Canaccord analyst Katie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PMETF Patriot Battery Metals
$8.35 /

+0.126 (+1.53%)

PMETF Patriot Battery Metals
$8.35 /

+0.126 (+1.53%)

02/28/23 Stifel
Patriot Battery Metals price target raised to C$16 from C$8.25 at Stifel
02/01/23 Canaccord
Patriot Battery Metals price target raised to C$16.50 from C$9.75 at Canaccord
11/30/22 Stifel
Patriot Battery Metals initiated with a Speculative Buy at Stifel
10/17/22 Canaccord
Patriot Battery Metals initiated with a Speculative Buy at Canaccord
Recommendations
Osisko Gold price target raised to C$25.50 from C$23 at Canaccord » 12:10
03/27/23
03/27
12:10
03/27/23
12:10
OR

Osisko Gold

$15.04 /

+0.03 (+0.20%)

Canaccord analyst Carey…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OR Osisko Gold
$15.04 /

+0.03 (+0.20%)

OR Osisko Gold
$15.04 /

+0.03 (+0.20%)

07:44 Today Canaccord
Osisko Gold price target raised to C$25.50 from C$23 at Canaccord
03/01/23 TD Securities
Osisko Gold price target lowered to C$22 from C$24 at TD Securities
02/27/23 Raymond James
Osisko Gold price target lowered to C$22 from C$22.50 at Raymond James
02/15/23 BMO Capital
Osisko Gold price target raised to C$21 from C$18 at BMO Capital
Recommendations
Hammond Power Solutions price target raised to C$41.50 from C$29 at Canaccord » 12:10
03/27/23
03/27
12:10
03/27/23
12:10
HMDPF

Hammond Power Solutions

$25.72 /

-0.0287 (-0.11%)

Canaccord raised the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HMDPF Hammond Power Solutions
$25.72 /

-0.0287 (-0.11%)

10/31/22 Canaccord
Hammond Power Solutions price target raised to C$29 from C$22 at Canaccord
10/28/22 Canaccord
Hammond Power Solutions price target raised to C$29 from C$22 at Canaccord
04/13/22 Canaccord
Hammond Power Solutions initiated with a Buy at Canaccord

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.